In line with these studies, using the NALM-6 tumor treated mouse, we found IL-15 armored CD19-CAR-T cells completely inhibited tumor relapse; however, the toxicity was serious that all mice died within 70 days with serious liver damage and higher GVHD score, indicating a severe adverse effect of IL-15. Here, CD19 is linked to neoplasm.